Showing results (161-170 of 191) with videos related to

Sort By:
Pageof 20
Lung Cancer (Amsterdam, Netherlands)|November 1, 1996
Tallimustine is inactive in patients with previously treated small cell lung cancer. A phase II trial of the National Cancer Institute of Canada Clinical Trials GroupJ Viallet, D Stewart, F Shepherd, et al.
Revue Neurologique|January 1, 1982
[Crossed aphasia in right-handed patients. II. Neuropsychological and neurolinguistic study of a case. Evolution over a 2 year period]M Puel, Y Joanette, M Levrat, et al.
Cancer|September 1, 1982
Benefits of polychemotherapy in advanced non-small-cell bronchogenic carcinomaY Cormier, D Bergeron, J La Forge, et al.
The European Respiratory Journal|October 2, 2004
Occupational asthma in newly employed workers in intensive swine confinement facilitiesJ A Dosman, J A Lawson, S P Kirychuk, et al.
Equine Veterinary Journal|May 1, 1993
Effect of stabling on bronchoalveolar cells obtained from normal and COPD horsesG M Tremblay, C Ferland, J M Lapointe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Phase I dose-escalation trial of gemcitabine and cisplatin for advanced non-small-cell lung cancer: usefulness of mathematic modeling to determine maximum-tolerable doseF A Shepherd, R Burkes, Y Cormier, et al.
Neurobiology of Aging|January 1, 1996
Longitudinal study of basal cortisol levels in healthy elderly subjects: evidence for subgroupsS Lupien, A R Lecours, G Schwartz, et al.
Brain and Language|March 1, 1988
Agrammatism in sentence production without comprehension deficits: reduced availability of syntactic structures and/or of grammatical morphemes? A case studyJ L Nespoulous, M Dordain, C Perron, et al.
Seminars in Oncology|October 1, 1996
Final results of the Canadian phase I dose escalation trial of gemcitabine and cisplatin for advanced non-small cell lung cancerF A Shepherd, R L Burkes, Y Cormier, et al.
The American Review of Respiratory Disease|July 1, 1993
Farmer's lung. Long-term outcome and lack of predictive value of bronchoalveolar lavage fibrosing factorsM Lalancette, G Carrier, M Laviolette, et al.
Pageof 20